|
|
| LMBL1_HUMAN |
L3MBTL1 |
Lethal(3)malignant brain tumor-like protein 1 |
1.263e-191 |
0.53
|
| LMBL3_HUMAN |
L3MBTL3 |
Lethal(3)malignant brain tumor-like protein 3 |
5.167e-178 |
0.53
|
| MBTD1_HUMAN |
MBTD1 |
MBT domain-containing protein 1 |
2.892e-125 |
0.50
|
| TP53B_HUMAN |
TP53BP1 |
TP53-binding protein 1 |
5.397e-88 |
0.47
|
| NEMO_HUMAN |
IKBKG |
NF-kappa-B essential modulator |
6.923e-64 |
0.39
|
| CALCA_HUMAN |
CALCA |
Calcitonin gene-related peptide 1 |
1.672e-63 |
0.32
|
| LMBL4_HUMAN |
L3MBTL4 |
Lethal(3)malignant brain tumor-like protein 4 |
2.374e-54 |
0.43
|
| BKRB1_MACFA |
BDKRB1 |
B1 bradykinin receptor |
5.678e-50 |
0.43
|
| OGRL1_HUMAN |
OGFRL1 |
Opioid growth factor receptor-like protein 1 |
2.77e-49 |
0.35
|
| Q8MHZ5_SHEEP |
|
Ghrelin/growth hormone secretagogue receptor |
4.82e-48 |
0.33
|
| TRPV4_RAT |
Trpv4 |
Transient receptor potential cation channel subfamily V member 4 |
1.355e-47 |
0.32
|
| CCR3_MACMU |
CCR3 |
C-C chemokine receptor type 3 |
1.756e-43 |
0.35
|
| ACACA_HUMAN |
ACACA |
Acetyl-CoA carboxylase 1 |
2.873e-40 |
0.37
|
| HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
2.013e-36 |
0.40
|
| V1BR_HUMAN |
AVPR1B |
Vasopressin V1b receptor |
7.397e-36 |
0.34
|
| NPC1_HUMAN |
NPC1 |
NPC intracellular cholesterol transporter 1 |
2.748e-31 |
0.32
|
| V1AR_RAT |
Avpr1a |
Vasopressin V1a receptor |
1.282e-23 |
0.36
|
| Q6A2E2_AEDAE |
ace-1 |
Acetylcholinesterase |
1.444e-23 |
0.29
|
| ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
9.166e-23 |
0.36
|
| FAS_HUMAN |
FASN |
Fatty acid synthase |
1.499e-21 |
0.32
|
| KDM2A_HUMAN |
KDM2A |
Lysine-specific demethylase 2A |
8.489e-21 |
0.35
|
| Q1HEC0_RAT |
|
Acetyl-Coenzyme A carboxylase 2 |
2.208e-20 |
0.32
|
| PADI4_HUMAN |
PADI4 |
Protein-arginine deiminase type-4 |
2.341e-19 |
0.31
|
| TRPV4_HUMAN |
TRPV4 |
Transient receptor potential cation channel subfamily V member 4 |
4.895e-19 |
0.32
|
| O70424_RAT |
|
Neuropeptide Y-Y2 receptor |
8.07e-19 |
0.30
|
| CALRL_HUMAN |
CALCRL |
Calcitonin gene-related peptide type 1 receptor |
7.541e-18 |
0.33
|
| CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
1.585e-17 |
0.39
|
| PGDH_HUMAN |
HPGD |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] |
2.83e-17 |
0.39
|
| BKRB1_RAT |
Bdkrb1 |
B1 bradykinin receptor |
3.331e-16 |
0.35
|
| KDM5C_HUMAN |
KDM5C |
Lysine-specific demethylase 5C |
4.441e-16 |
0.35
|
| ACACA_RAT |
Acaca |
Acetyl-CoA carboxylase 1 |
5.884e-15 |
0.33
|
| FAS_RAT |
Fasn |
Fatty acid synthase |
1.632e-14 |
0.30
|
| V1BR_RAT |
Avpr1b |
Vasopressin V1b receptor |
5.576e-13 |
0.30
|
| PARP1_HUMAN |
PARP1 |
Poly [ADP-ribose] polymerase 1 |
6.675e-13 |
0.38
|
| CCR4_MOUSE |
Ccr4 |
C-C chemokine receptor type 4 |
1.326e-12 |
0.28
|
| CNR2_HUMAN |
CNR2 |
Cannabinoid receptor 2 |
7.881e-12 |
0.48
|
| CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
8.899e-12 |
0.48
|
| NMT_CANAL |
NMT1 |
Glycylpeptide N-tetradecanoyltransferase |
1.03e-11 |
0.32
|
| CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
1.04e-11 |
0.47
|
| MRGX2_HUMAN |
MRGPRX2 |
Mas-related G-protein coupled receptor member X2 |
1.107e-11 |
0.28
|
| DUS22_HUMAN |
DUSP22 |
Dual specificity protein phosphatase 22 |
2.835e-11 |
0.28
|
| AA1R_CAVPO |
ADORA1 |
Adenosine receptor A1 |
2.889e-11 |
0.30
|
| CCNC_HUMAN |
CCNC |
Cyclin-C |
7.677e-11 |
0.33
|
| ACACB_HUMAN |
ACACB |
Acetyl-CoA carboxylase 2 |
9.344e-11 |
0.37
|
| Q9FD53_STREE |
mvaD |
Diphosphomevalonate decarboxylase |
1.105e-10 |
0.29
|
| HPPD_HUMAN |
HPD |
4-hydroxyphenylpyruvate dioxygenase |
1.285e-10 |
0.28
|
| Q8JXU8_9HEPC |
NS5B |
RNA-directed RNA polymerase |
1.653e-10 |
0.35
|
| IKKA_HUMAN |
CHUK |
Inhibitor of nuclear factor kappa-B kinase subunit alpha |
5.006e-10 |
0.39
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
2.201e-09 |
0.43
|
| DCPS_MOUSE |
Dcps |
m7GpppX diphosphatase |
2.851e-09 |
0.29
|
| NK2R_RABIT |
TACR2 |
Substance-K receptor |
3.5e-09 |
0.30
|
| CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
3.633e-09 |
0.32
|
| HRH3_RAT |
Hrh3 |
Histamine H3 receptor |
6.683e-09 |
0.37
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
1.353e-08 |
0.34
|
| PTR1_LEIMA |
PTR1 |
Pteridine reductase 1 |
1.639e-08 |
0.30
|
| PDE3B_HUMAN |
PDE3B |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B |
1.737e-08 |
0.31
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
1.775e-08 |
0.36
|
| MK07_HUMAN |
MAPK7 |
Mitogen-activated protein kinase 7 |
4.592e-08 |
0.38
|
| DHI1_HUMAN |
HSD11B1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 |
8.139e-08 |
0.33
|
| PDE3A_HUMAN |
PDE3A |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A |
9.369e-08 |
0.31
|
| OXYR_HUMAN |
OXTR |
Oxytocin receptor |
1.359e-07 |
0.31
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
1.366e-07 |
0.34
|
| P2Y12_HUMAN |
P2RY12 |
P2Y purinoceptor 12 |
3.166e-07 |
0.31
|
| ERN1_HUMAN |
ERN1 |
Serine/threonine-protein kinase/endoribonuclease IRE1 |
3.508e-07 |
0.32
|
| CDK8_HUMAN |
CDK8 |
Cyclin-dependent kinase 8 |
6.71e-07 |
0.33
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
9.602e-07 |
0.33
|
| Q9BJF5_TOXGO |
CDPK1 |
Calmodulin-domain protein kinase 1 |
1.486e-06 |
0.31
|
| NK1R_CAVPO |
TACR1 |
Substance-P receptor |
1.576e-06 |
0.30
|
| ACM1_RAT |
Chrm1 |
Muscarinic acetylcholine receptor M1 |
1.663e-06 |
0.33
|
| CSK2A_MAIZE |
ACK2 |
Casein kinase II subunit alpha |
1.924e-06 |
0.28
|
| LRRK2_HUMAN |
LRRK2 |
Leucine-rich repeat serine/threonine-protein kinase 2 |
2.413e-06 |
0.46
|
| Q70GC6_9HEPC |
NS5B |
RNA-directed RNA polymerase |
2.438e-06 |
0.29
|
| SC6A4_HUMAN |
SLC6A4 |
Sodium-dependent serotonin transporter |
3.299e-06 |
0.36
|
| CCR4_HUMAN |
CCR4 |
C-C chemokine receptor type 4 |
3.427e-06 |
0.32
|
| ADCY5_RAT |
Adcy5 |
Adenylate cyclase type 5 |
3.847e-06 |
0.29
|
| VACHT_TETCF |
|
Vesicular acetylcholine transporter |
3.973e-06 |
0.29
|
| AL1A1_HUMAN |
ALDH1A1 |
Retinal dehydrogenase 1 |
6.493e-06 |
0.32
|
| NPCL1_HUMAN |
NPC1L1 |
NPC1-like intracellular cholesterol transporter 1 |
6.587e-06 |
0.29
|
| AA1R_HUMAN |
ADORA1 |
Adenosine receptor A1 |
8.766e-06 |
0.33
|
| RPA1_HUMAN |
POLR1A |
DNA-directed RNA polymerase I subunit RPA1 |
8.833e-06 |
0.28
|